The focus of the current study is to assess the effects of concurrent activation of LXR and PPARα on systemic metabolism and hepatic fat accumulation under the status of obesity in which the metabolism of glucose and lipids are dysregulated. Here, PPARA is linked to obesity due to melanocortin 4 receptor deficiency.